Back to catalogue
№ 085 44 filings · 2021-10-19 → 2026-09-23

B.P. MARSH & PARTNERS PLC

BPM
Financial Services Share price 665p Market cap £235m Overall fit 380 /1000

Partial fit: attractive at a 32% discount to a validated NAV, with a quality portfolio and fortress balance sheet, but minimal AI-receiver exposure and only modest operating leverage. Insurance intermediaries are not the picks-and-shovels the strategy targets.

Fair value range 720p–820p Mid case · £272m
Absolute upside +15.6% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • NAV methodology externally validated by multiple exits at or above carrying value (SSRU +20.5%, Paladin +38%, Lilley Plummer +26%)
  • 36-year track record of 11.0% CAGR NAV growth with no major stumbles and transparent IPEV-compliant disclosure
  • Debt-free balance sheet with £37.4m cash and £46.9m loan book earning 8.3% — dividend coverage not dependent on fire-sale realisations
Limits the call
  • Material portion of reported earnings is unrealised fair-value gains with 10% multiple sensitivity worth £25.5m
  • Appropriate NAV discount is itself judgmental — 25-30% vs 15-20% dramatically changes the upside calculation
Methodology

Discount to fully diluted NAV per share

In one line · bull case

A specialist private-equity investor in insurance intermediaries with a 36-year 11% NAV CAGR track record, available at a c.32% discount to a conservatively marked and exit-validated NAV, with a debt-free balance sheet and a step-change in capital returns.

In one line · biggest risk

Prolonged soft commercial insurance rate cycle compresses portfolio broker/MGA earnings and triggers downward NAV revaluation via lower exit multiples.

Drivers
AI beneficiary 15 /100
Insurance intermediary portfolio with no direct AI revenue line; management explicitly frames AI as net enabler not value driver.
Operating leverage 35 /100
Commission-based broker/MGA portfolio with modest fixed-cost base; incremental revenue scales mostly linearly with compensation.
Earnings vs expectations 65 /100
Consistently beats implied trading-update signposts; exits systematically price above carrying values.
Growth momentum 60 /100
Steady 10%+ NAV growth with portfolio companies collectively placing £2.3bn of premium and a strong new-business pipeline (45 enquiries H1 FY27).
Moat 50 /100
Reputation and 35-year sourcing network provides deal-flow moat but no structural network effect or switching cost.
Earnings quality 55 /100
Reported earnings dominated by unrealised fair-value gains; underlying cash profit modest (£12.2m FY26) but exit realisations validate marks.
Management quality 78 /100
Transparent capital allocation, consistent dividend progression, successful exits at IRRs of 48-93%; founder transition to Life President well-managed.
Cyclicality 45 /100
Specialty insurance niches less cyclical than headline P&C but exposed to the broader commercial rate cycle currently softening.
Leverage 5 /100
Debt-free with £37.4m funds and a £46.9m yielding loan book — fortress balance sheet.

B.P. Marsh & Partners PLC (BPM) — Research Note

Executive summary

B.P. Marsh is an AIM-listed specialist private equity investor that takes long-dated minority stakes in early-stage insurance intermediaries (brokers and underwriting agencies) across the UK, US, Australia and Europe, supplementing equity with secured loans. Across the five-year period covered, the group has grown NAV from c.£150m to £360.2m at 31 Jan 2026 (11.0% CAGR since IPO), executed a series of highly profitable realisations (Kentro, Paladin/CBC, Lilley Plummer, Stewart Specialty, Sterling) at prices generally above carrying value, and stepped up the dividend materially (£13.0m intended in FY27 vs £2.0m in FY24). The single most important point for valuation today is that the shares trade at 649p versus a fully diluted NAV per share of 959.8p — a c.32% discount to an NAV that has consistently been validated by exit multiples 2026-05 full-year.

Fair value estimate

Methodology: Discount-to-NAV applied to the fully diluted NAV per share at 31 Jan 2026 of 959.8p. This is appropriate because BPM is an investment entity reporting fair value under IPEV guidelines, and because recent realisations (Kentro at 100% of carried value, SSRU at a 20.5% uplift to carrying value, Paladin ultimately at 38% uplift) corroborate the methodology.

Key assumptions:

  • NAV growth continues at the long-run average (c.10%+); portfolio further seasons through FY27-28.
  • Appropriate steady-state discount: 20% at the mid-point, bracketed 15–25%, reflecting (a) AIM small-cap illiquidity, (b) partial inability to buy back shares without triggering a mandatory offer by the Marsh concert party (currently c.39.4%), and (c) the long holding periods required to realise portfolio value.

Fair value range: 720p – 820p per share, mid 770p, implied market cap £255m – £290m (mid £272m) vs current £229.3m. Absolute upside to mid: ~19%.

Compared to the current 32% discount to NAV, this fair value implies modestly undervalued. A buyer taking NAV at face value (0% discount) sees c.48% upside, but a steady-state discount is appropriate for AIM-listed investment companies.

Sector context

Confirmed classification: Financial Services (Financials). BPM is not a typical broker or underwriter — it is a listed specialist investment company, and its earnings are predominantly fair-value gains on unquoted holdings. Its quality profile is above typical AIM investment-company peers (long track record, repeatable exit outcomes, debt-free balance sheet, cash dividends). Listed comparators are imperfect but include specialist financials investors (e.g. Mercia Asset Management, Oakley Capital Investments) and insurance intermediary consolidators that BPM has sold into (Ryan Specialty, Brown & Brown, Specialist Risk Group — these are acquirers, not peers). No direct listed peer replicates the model.

Investment thesis (3 bullets)

  • Validated NAV with 32% discount gives a margin of safety. Multiple recent exits have crystallised at or above carrying value — SSRU at 20.5% uplift, Paladin at 38%, Lilley Plummer at 26%, aggregate realised gains £178.9m from £20.6m invested capital (8.7x) over five years 2026-05 full-year. Buying at a 32% discount to NAV that has consistently been proven conservative is the core bull case.
  • Strong cash return programme and robust balance sheet. FY27 dividends of £13.0m (36.29p) comprising interim + final + special, with £7.0m minimum intended for FY28, plus active buyback at 677p average 2026-09 trading update. Group is debt-free with £37.4m funds at 31 July 2026 and a £46.9m loan book earning 8.3%, so dividend capacity is well-covered without forced sales.
  • Deep, diversified, scaling portfolio with headline positions compounding. Pantheon (now 41%, carried at £107m) is budgeting £27.7m revenue in FY26 up from £23.8m; XPT grew to $900m GWP; ATC is largest independent MGA in Australia. Portfolio companies collectively write £2.3bn of insurance premium globally 2026-05 full-year. Pipeline remains strong — 45 new enquiries in H1 FY27 vs 32 prior year 2026-09 trading update.

Key risks (3 bullets)

  • Softening commercial insurance rates reduce portfolio growth tailwind. Global commercial rates declined 6% in Q2 2026 — the eighth consecutive quarter of declines, with UK rates down 8% and property down 12% 2026-09 trading update. BPM's thesis is that specialty niches are more resilient, but a prolonged soft cycle compresses MGA commissions and broker fees across the portfolio.
  • Concentration risk and NAV-mark subjectivity. Pantheon (£107m), XPT (£64m) and ATC (£38m) together represent c.58% of equity portfolio value. All are valued via earnings multiples (12.7x weighted-average post-discount EBITDA at FY26); a 10% move in the multiple shifts portfolio value by £25.5m / 9.3% 2026-05 full-year. Mark-to-market gains dominate reported profits.
  • Concert party overhang limits capital return flexibility. The Brian Marsh concert party holds 39.4% and buybacks are constrained by Rule 9 of the Takeover Code; shareholders approved a waiver up to 47.78%, which gives runway but ultimately caps the pace of return of capital via buybacks 2026-06 Notice of AGM.

Operating leverage

BPM itself is an investment company — the parent entity has modest fixed costs (FY26 operating expenses £14.8m against operating income of £62.7m, giving a c.76% operating margin that is largely dependent on fair-value gains). The 18-person head office cost base is substantially fixed, so incremental NAV growth drops disproportionately to profit at the parent level, but headline reported earnings are dominated by unrealised revaluations rather than cash leverage. At the portfolio level, individual brokers/MGAs have modest operating leverage — commission-based businesses where variable costs (producer compensation) scale with revenue, with some fixed-cost platforms (compliance, technology, central management). Pantheon's margins are described as "strong" with "significant cash generation" and the loan book earns 8.3% — but this is not a pure fixed-cost software model where a 10% revenue surprise doubles profit. A 10–20% beat on portfolio GWP would plausibly add 15–30% to aggregate portfolio EBITDA, which translates (via NAV multiples) into a similar order of NAV uplift — meaningful but not multi-bagger operating leverage 2026-05 full-year.

Value-trap signals

None identified. The portfolio is growing, the balance sheet is debt-free with 8.7x realised-money-multiple history, management is transparent, exits are consistently near or above carried values, and the dividend is covered by realisations. The discount to NAV is a function of AIM illiquidity and the concert-party overhang, not deteriorating fundamentals.

Earnings vs expectations

BPM is an investment company with no quarterly guidance regime and no visible sell-side consensus in the filings. Measurable against management targets/trading-update signposts: FY26 trading update 2026-02 trading update guided to "continued strong performance" and signposted an exit-driven uplift from the SSRU sale; the full-year result delivered 10.3% NAV growth and a 12.8% total shareholder return 2026-05 full-year. Each half-year/full-year result has either met or beaten the implied trajectory in the preceding trading update. Pattern: BPM consistently delivers NAV outcomes consistent with (and in some years materially ahead of) the signposts in its interim trading updates, and the exit prices have systematically beaten carrying values — a pattern of under-promising on NAV marks.

Conviction

Conviction: 4 — high.

Anchoring factors: (1) NAV methodology is well-disclosed, applies IPEV guidelines, and has been externally validated by multiple exits at or above carrying value; (2) 36-year track record with 11.0% CAGR since IPO and no major stumbles disclosed; (3) debt-free balance sheet with clear cash availability.

Limiting factors: (1) material portion of reported earnings is unrealised fair-value gains — a different valuer could land 10-15% different given multiple-sensitivity; (2) the appropriate discount to apply to NAV is itself judgmental — a wider discount (25-30%) would eliminate most of the upside, while a narrower discount (10-15%) would make the shares look very cheap.


Driver scoring and overall score

Importantly for this investor's strategy: BPM has no meaningful AI-receiver exposure. Management's own commentary describes AI as a "net enabler" supporting automation and data management across insurance intermediaries, with the value capture flowing to tooling vendors — not to BPM's portfolio companies 2026-09 trading update, 2026-05 full-year. The portfolio is insurance distribution; incremental AI spend by the insurance industry does not meaningfully accrue to brokers and MGAs the way it accrues to semiconductor/data-centre/cybersecurity names. Operating leverage is also modest — these are predominantly commission-based businesses, not fixed-cost software platforms. The attraction here is quality + valuation + downside protection, not AI exposure or operating-leverage torque.

Filings consulted · 57

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-23Notice OF HY Results And Investor Presentation2026-09-23_9785643_notice-of-hy-results-and-investor-presentation.md0.70
  2. 2026-09-22Trading Update2026-09-22_9783174_trading-update.md0.85
  3. 2026-07-08Result OF Agm2026-07-08_9658702_result-of-agm.md0.30
  4. 2026-06-16Notice OF Agm2026-06-16_9619646_notice-of-agm.md0.30
  5. 2026-06-16Final Dividend Declaration2026-06-16_9619748_final-dividend-declaration.md0.30
  6. 2026-05-27Final Results For The Year TO 31 January 20262026-05-27_9586628_final-results-for-the-year-to-31-january-2026.md1.00
  7. 2026-05-06Notice OF Results And Investor Presentation2026-05-06_9553647_notice-of-results-and-investor-presentation.md0.70
  8. 2026-04-16Deferred Consideration Receipt Amp Special Dividend2026-04-16_9522668_deferred-consideration-receipt-amp-special-dividend.md0.30
  9. 2026-02-24Trading Update2026-02-24_9443344_trading-update.md0.72
  10. 2026-01-21Interim Dividend Declaration2026-01-21_9370908_interim-dividend-declaration.md0.26
  11. 2025-12-15Special Dividend Declaration2025-12-15_9295762_special-dividend-declaration.md0.26
  12. 2025-10-21Half Year Results2025-10-21_9183082_half-year-results.md0.77
  13. 2025-10-07Notice OF HY Results And Investor Presentation2025-10-07_9155703_notice-of-hy-results-and-investor-presentation.md0.46
  14. 2025-09-23Trading Update2025-09-23_9124498_trading-update.md0.55
  15. 2025-08-07Result OF Secondary Placing2025-08-07_9033704_result-of-secondary-placing.md0.46
  16. 2025-08-06Proposed Secondary Placing2025-08-06_9032852_proposed-secondary-placing.md0.46
  17. 2025-07-17Result OF Agm2025-07-17_8985076_result-of-agm.md0.20
  18. 2025-06-24Notice OF Agm Correction2025-06-24_8945595_notice-of-agm-correction.md0.20
  19. 2025-06-24Notice OF Agm2025-06-24_8945337_notice-of-agm.md0.20
  20. 2025-06-10Final Results For The Year TO 31 January 20252025-06-10_8920566_final-results-for-the-year-to-31-january-2025.md0.65
  21. 2025-06-10Final Dividend Declaration2025-06-10_8921974_final-dividend-declaration.md0.20
  22. 2025-06-04Notice OF Annual Results And Investor Presentation2025-06-04_8912684_notice-of-annual-results-and-investor-presentation.md0.65
  23. 2025-05-09Result OF Secondary Placing2025-05-09_8870823_result-of-secondary-placing.md0.46
  24. 2025-05-08Proposed Secondary Placing2025-05-08_8868747_proposed-secondary-placing.md0.46
  25. 2025-04-16Special Dividend Declaration2025-04-16_8835300_special-dividend-declaration.md0.20
  26. 2025-02-24Trading Statement2025-02-24_8748413_trading-statement.md0.55
  27. 2025-01-23Interim Dividend Declaration2025-01-23_8701803_interim-dividend-declaration.md0.20
  28. 2024-10-23Half Year Results2024-10-23_8502624_half-year-results.md0.58
  29. 2024-10-09Notice OF HY Results And Investor Presentation2024-10-09_8475699_notice-of-hy-results-and-investor-presentation.md0.46
  30. 2024-09-17Trading Statement2024-09-17_8419669_trading-statement.md0.38
  31. 2024-07-23Result OF Agm2024-07-23_8326505_result-of-agm.md0.14
  32. 2024-06-27Notice OF Agm Amp Change OF Name OF Nomad And Broker2024-06-27_8283009_notice-of-agm-amp-change-of-name-of-nomad-and-broker.md0.27
  33. 2024-06-11Final Results For The Year TO 31 January 20242024-06-11_8252115_final-results-for-the-year-to-31-january-2024.md0.45
  34. 2024-03-25Completion OF Sale And Dividend Declaration2024-03-25_8103682_completion-of-sale-and-dividend-declaration.md0.14
  35. 2024-02-19Trading Update2024-02-19_8043384_trading-update.md0.38
  36. 2024-02-07Interim Dividend Declaration2024-02-07_8027114_interim-dividend-declaration.md0.14
  37. 2023-11-13Investee Company Update Disposal BY Lebc OF Aspira2023-11-13_7877096_investee-company-update-disposal-by-lebc-of-aspira.md0.34
  38. 2023-10-17Half Year Results2023-10-17_7820326_half-year-results.md0.41
  39. 2023-10-11Notice OF Half Year Results2023-10-11_7810710_notice-of-half-year-results.md0.41
  40. 2023-09-18Trading Statement2023-09-18_7760508_trading-statement.md0.21
  41. 2023-07-26Result OF Agm2023-07-26_7656958_result-of-agm.md0.07
  42. 2023-06-30Notice OF Agm2023-06-30_7604527_notice-of-agm.md0.07
  43. 2023-06-13Final Results2023-06-13_7571366_final-results.md0.25
  44. 2023-05-23Notice OF Annual Results And Investor Presentation2023-05-23_7539721_notice-of-annual-results-and-investor-presentation.md0.25
  45. 2023-02-14Trading Update2023-02-14_7451745_trading-update.md0.21
  46. 2022-10-18Interim Results2022-10-18_7351311_interim-results.md0.23
  47. 2022-10-06Notice OF Interim Results Amp Investor Presentation2022-10-06_7250575_notice-of-interim-results-amp-investor-presentation.md0.23
  48. 2022-09-13Trading Update2022-09-13_7311817_trading-update.md0.21
  49. 2022-07-25Result OF Agm2022-07-25_7135829_result-of-agm.md0.07
  50. 2022-07-01Notice OF Agm2022-07-01_7153930_notice-of-agm.md0.07
  51. 2022-06-21Investor Presentation Change OF Date2022-06-21_7022539_investor-presentation-change-of-date.md0.17
  52. 2022-06-13Final Results2022-06-13_6937297_final-results.md0.25
  53. 2022-03-01Completion OF Disposal2022-03-01_6963694_completion-of-disposal.md0.19
  54. 2022-02-08Trading Update2022-02-08_6749145_trading-update.md0.21
  55. 2022-01-11Investee Company Disposal Summa Insurance2022-01-11_6807789_investee-company-disposal-summa-insurance.md0.19
  56. 2021-12-22Investee Company Disposal Walsingham Motor2021-12-22_6913209_investee-company-disposal-walsingham-motor.md0.19
  57. 2021-10-19Interim Results2021-10-19_6816734_interim-results.md0.23

This research note was authored by a large language model after reading 44 regulatory filings published between 2021-10-19 and 2026-09-23. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.